Genzyme
Genzyme cuts forecasts on production problems
July 29, 2009Manufacturing and Production, Sales and Marketing Genzyme
The contamination problems at Genzyme's Allston Landing production plants have caused the firm to scale back its revenue forecasts for …
Genzyme’s woes are a boost for Shire and Protalix
July 9, 2009Research and Development, Sales and Marketing FDA, Genzyme, US
The contamination problems at a plant used by Genzyme to manufacture a drug for Gaucher disease have prompted the US …
Pharmaceutical manufacturing: news in brief
July 6, 2009Manufacturing and Production Genzyme, Quotient
Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Genzyme, Caraco, MSD, Rottapharm and Almac Pharma Services, …
Pharmaceutical manufacturing: news in brief
June 22, 2009Manufacturing and Production Genzyme
Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Genzyme, Norwich Pharma and Kemwell/Boehringer Ingelheim, progress with …
Genzyme buys rights to Bayer MS candidate
June 4, 2009Sales and Marketing Bayer, Genzyme
Genzyme has bought the global rights multiple sclerosis (MS) candidate Campath/MabCampath from Bayer HealthCare.Originally discovered by Genzyme, Campath (alemtuzumab) is …
Pharma manufacturing: news in brief
May 12, 2009Manufacturing and Production Genzyme
Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including new capital investments at Roche, Genzyme and Aeras, …
Blow for Genzyme as FDA finds fault with Allston facility
March 13, 2009Research and Development, Sales and Marketing FDA, Genzyme
The chances of approval for Genzyme's new Pompe disease drug Lumizyme have diminished dramatically after the US Food and Drug …
Genzyme says new plant approval is imminent
February 18, 2009Research and Development, Sales and Marketing Genzyme
Genzyme has said it expects to get approval to make a Pompe disease treatment at a new US manufacturing unit …
